| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-A86708339 | CTRPv2 | pan-cancer | AAC | 0.25 | 2e-06 |
| mRNA | navitoclax:sorafenib (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.18 | 2e-06 |
| mRNA | tubastatin A | GDSC1000 | pan-cancer | AAC | 0.15 | 2e-06 |
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | 0.16 | 2e-06 |
| mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | 0.19 | 3e-06 |
| mRNA | ATRA | CTRPv2 | pan-cancer | AAC | 0.17 | 3e-06 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | 0.23 | 3e-06 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | 0.15 | 3e-06 |
| mRNA | BRD-K80183349 | CTRPv2 | pan-cancer | AAC | 0.16 | 4e-06 |
| mRNA | palmostatin B | CTRPv2 | pan-cancer | AAC | 0.22 | 4e-06 |